| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000027532 |
| Receipt No. | R000031450 |
| Scientific Title | Evaluation of the usefulness of positive end expiratory pressure and recruitment maneuver using change in gas distribution in lung observed from electric impedance tomography device in robotic-assisted laparoscopic prostatectomy during perioperative surgery |
| Date of disclosure of the study information | 2017/06/01 |
| Last modified on | 2022/07/06 (Ver. 4) |
| Basic information | ||
| Public title | Evaluation of the usefulness of positive end expiratory pressure and recruitment maneuver using change in gas distribution in lung observed from electric impedance tomography device in robotic-assisted laparoscopic prostatectomy during perioperative surgery | |
| Acronym | Usefulness of PEEP and RM in robotic-assisted laparoscopic prostatectomy | |
| Scientific Title | Evaluation of the usefulness of positive end expiratory pressure and recruitment maneuver using change in gas distribution in lung observed from electric impedance tomography device in robotic-assisted laparoscopic prostatectomy during perioperative surgery | |
| Scientific Title:Acronym | Usefulness of PEEP and RM in robotic-assisted laparoscopic prostatectomy | |
| Region |
|
|
| Condition | |||
| Condition | prostate cancer | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | In order to search for more suitable artificial respiration setting to prevent atelectasis or hypoventilation in laparoscopic surgery with trendelenburg position, typified by robotic-assisted laparoscopic prostatectomy, we investigate the usefulness of positive end expiratory pressure and recruitment maneuver from transition of gas distribution change in lung and of functional residual capacity. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Changes in regional lung gas distribution obtained from EIT device and functional residual capacity change suggested by EELI among three groups with different settings of PEEP and RM at 8 time points (at the time of entering the room, introducing the general anesthesia, before starting the operation, 1 hour after the start of pneumoperitoneum and trendelenburg position, 2 hours after the start of pneumoperitoneum and trendelenburg position, immediately after the operation, 5 minutes afuter extubation). |
| Key secondary outcomes | Lung compliance obtained from ventilator and blood gas analysis result obtained by arterial blood sampling among three groups with different settings of PEEP and RM at 8 time points (at the time of entering the room, introducing the general anesthesia, before starting the operation, 1 hour after the start of pneumoperitoneum and trendelenburg position, 2 hours after the start of pneumoperitoneum and trendelenburg position, immediately after the operation, 5 minutes afuter extubation). |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Dose comparison |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 3 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Interventions 1: PEEP (2) RM (-) | |
| Interventions/Control_2 | Interventions 2: PEEP (10) RM (-) | |
| Interventions/Control_3 | Interventions 3: PEEP (10) RM (+) | |
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male | |||
| Key inclusion criteria | Adult patients undergoing robotic-assisted laparoscopic prostatectomy with ASA physical status 1-2 | |||
| Key exclusion criteria | Patients under 20 years of age, pregnant women, Hugh-Jones class III or above, patients with bulla in the lung | |||
| Target sample size | 60 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Showa University | ||||||
| Division name | Department of Anesthesiology | ||||||
| Zip code | 1428555 | ||||||
| Address | 1-5-8, Hatanodai, Shinagawa-ku, Tokyo, Japan | ||||||
| TEL | 03-3784-8000(ext.3540) | ||||||
| kiyokobitoxxx@s5.dion.ne.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Showa University | ||||||
| Division name | Department of Anesthesiology | ||||||
| Zip code | 1428555 | ||||||
| Address | 1-5-8, Hatanodai, Shinagawa-ku, Tokyo, Japan | ||||||
| TEL | 03-3784-8000(ext.3540) | ||||||
| Homepage URL | |||||||
| kiyokobitoxxx@s5.dion.ne.jp | |||||||
| Sponsor | |
| Institute | Showa University
Department of Anesthesiology |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Showa University
Department of Anesthesiology |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Showa University Clinical Research Institute for Clinical Pharmacology and Therapeutics|Showa University Hospital Clinical Trial Support Center |
| Address | 1-5-8, Hatanodai, Shinagawa-ku, Tokyo, Japan |
| Tel | 03-3784-8000 |
| ctsc.admin@ofc.showa-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 昭和大学病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031450 |